WILMAR GARCIA: Open Payments
NPI 1740953439 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,992 in 118 payments from 14 companies in 2025. Trend: 2023 $1,115 · 2024 $825 · 2025 $1,992
Food & beverage: $1,762Education: $230
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $314 |
| Janssen Biotech, Inc. | 8 | $259 |
| Amgen Inc. | 13 | $210 |
| ABBVIE INC. | 17 | $207 |
| Novartis Pharmaceuticals Corporation | 19 | $201 |
| E.R. Squibb & Sons, L.L.C. | 17 | $190 |
| Galderma Laboratories, L.P. | 11 | $168 |
| LEO Pharma Inc. | 8 | $146 |
| UCB, Inc. | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
Products named: TREMFYA, OTEZLA, COSENTYX, Sotyktu, ILUMYA, NEMLUVIO, ADBRY, DUPIXENT.
Industry payments across IA — which companies pay providers there.
